MarketTwits@markettwitsФинансы и криптовалюты3 ноября 2026

🇩🇪#BNTX #отчетность BioNTech Q3 2026 Earnings -Adj EPS: €1.76 -Rev: €1.29B (est €1.02B) -Operating Income: €125.0M -Sees FY Rev: €1.70B To €1.90B (previously €1.60B To €1.90B) -Still Sees FY SG&A Expense: €700M To €800M (est €761.1M) -Still Sees FY R&D Expenses: €2.00B To €2.30B запускает buyback на $1 млрд

MarketTwits@markettwitsФинансы и криптовалютывчера
  • Фото поста канала  MarketTwits

🇪🇺#NVO #отчетность Novo Nordisk Q3 Earnings: - Adj Sales: DKK79.20B (est DKK73.55B) - Adj Net: DKK25.60B (est DKK21.47B) - Sees FY Adjusted Sales At CER: -2% To +2% (est -2.35%) - Sees FY Adjusted Operating Profit At CER: -2% To +2% - Ozempic Sales: DKK29.71B (est DKK27.19B) Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%

MarketTwits@markettwitsФинансы и криптовалютывчера
  • Фото поста канала  MarketTwits

🇺🇸#CVS #отчетность CVS Health Q3 2026 Earnings - Adj EPS: $2.09 (est $1.66) - Adj Oper Income: $4.19B (est $3.62B) - Net Rev: $108.4B (est $104.62B) - Sees FY Adj EPS: At Least $8.20 (prev $7.90 To $8.10; est $8.05) - Sees FY Rev At Least $420B, Saw At Least $414B Sees FY FCF From Ops At Least $15.5B (est $12.22B) - Confirm Retail Unit Separation, Say To Close In H1 2028